NCT01304303View on ClinicalTrials.gov

Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Solid Tumor in Advanced Stage
Interventions
DRUG

SPARC1023 I

IV administration

DRUG

SPARC1023 II

IV administration

Trial Locations (1)

Unknown

SPARC Site 1, Buffalo

All Listed Sponsors
lead

Sun Pharma Advanced Research Company Limited

INDUSTRY

NCT01304303 - Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination | Biotech Hunter | Biotech Hunter